Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

<p>Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery.</p>